syringe vision inspection

Common Issues in Prefilled Syringes and Effective Solutions

blog / By

Prefilled syringes (PFS) have become the preferred delivery system for injectable pharmaceuticals due to their convenience, accuracy, and safety. However, as with any sophisticated drug delivery device, prefilled syringes present a range of technical and material challenges that can impact product stability, usability, and patient safety. Understanding these issues—and implementing robust engineering and quality control solutions—is crucial for manufacturers seeking to ensure high product integrity and compliance with regulatory standards.

Overview of Prefilled Syringe Challenges

The evolution of prefilled syringes has introduced multiple components—glass barrels, elastomeric plungers, silicone lubricants, tungsten needles, and polymeric closures—each of which can interact with the drug formulation. These interactions, coupled with manufacturing complexity and regulatory constraints, make the control of prefilled syringe quality a multidimensional task.

Common problems can generally be categorized into chemical compatibility, mechanical performance, particulate contamination, and container closure integrity concerns.

1. Protein Aggregation and Particulate Contamination

Protein aggregation and particulate formation are among the most critical concerns for biologics packaged in prefilled syringes. Aggregation can reduce therapeutic efficacy, increase immunogenicity, and cause visible or sub-visible particles.

Causes

  • Interaction between protein formulations and container surfaces (glass, silicone oil, tungsten residues)

  • Incomplete removal of process residues or lubricants

  • Air bubble entrapment during filling or storage

  • Temperature or humidity fluctuations causing phase separation

Solutions

  • Use low-tungsten or tungsten-free syringe barrels to minimize catalytic degradation

  • Apply low-particle, baked-on silicone or switch to fluoropolymer-coated plungers to reduce oil droplet generation

  • Optimize filling processes to minimize air entrapment and turbulence

  • Conduct comprehensive stability and stress testing under accelerated and real-time conditions

2. Silicone Oil-Related Challenges

Silicone oil is essential for lubrication but can cause aggregation, micro-droplet formation, and sliding force inconsistencies.

Causes

  • Non-uniform silicone distribution inside the barrel

  • Excessive silicone leading to droplet release during storage or injection

  • Chemical interaction between silicone oil and drug formulations

Solutions

  • Implement baked-on siliconization to immobilize silicone oil on the barrel surface

  • Use alternative lubrication coatings, such as plasma-deposited fluoropolymers

  • Perform rheological testing of sliding and break-loose forces to define acceptable limits

  • Validate long-term compatibility between lubricant and formulation through extractable and leachable testing

3. Glass-Related Defects and Tungsten Residues

Glass syringes remain widely used for their transparency and dimensional stability, but they are susceptible to delamination, cracking, and metal contamination.

Causes

  • Residual tungsten from the needle-insertion manufacturing process

  • Alkali leaching from poor-quality glass under acidic formulations

  • Surface microcracks or delamination from thermal or mechanical stress

Solutions

  • Utilize low-tungsten forming processes or mechanically drilled tips

  • Choose Type I borosilicate glass or cyclic olefin polymer (COP/COC) alternatives for sensitive biologics

  • Apply surface treatment or coating to enhance chemical resistance

  • Conduct stress testing and delamination studies to ensure durability

4. Plunger Movement and Injection Force Issues

Inconsistent break-loose or glide forces can cause injection irregularities or device malfunction, especially when used in combination with autoinjectors.

Causes

  • Irregular or insufficient silicone lubrication

  • Plunger and barrel dimensional mismatches

  • Rubber composition with excessive hardness or low elasticity

Solutions

  • Optimize siliconization uniformity across the entire barrel

  • Select compatible elastomeric materials with validated frictional performance

  • Include mechanical performance testing (break-loose, glide force, extrusion force) during product design

  • Simulate autoinjector operation during validation to ensure consistent delivery performance

5. Fill Volume and Dose Accuracy Problems

Accurate fill volumes are critical for ensuring therapeutic efficacy and avoiding underdosing or overdosing.

Causes

  • Calibration drift in filling pumps or dosing systems

  • Variable backpressure or viscosity changes during filling

  • Air pockets or foaming in viscous formulations

Solutions

  • Regularly calibrate filling equipment using gravimetric or volumetric validation

  • Use in-line sensors and vision inspection systems to detect fill-level variation

  • Optimize filling speed, needle diameter, and backpressure to reduce turbulence

  • Employ automated rejection systems for syringes outside tolerance limits

6. Container Closure Integrity (CCI) Failures

Container closure integrity ensures sterility and prevents microbial ingress or product leakage during shelf life.

Causes

  • Improper plunger sealing or deformation

  • Microcracks in the barrel caused by handling or stress

  • Inadequate stopper compression or poor fit tolerance

Solutions

  • Conduct helium leak, vacuum decay, and microbial ingress tests to validate CCI

  • Optimize plunger geometry and elastomer composition for tight sealing

  • Implement robotic handling to reduce mechanical impact during assembly and packaging

  • Use real-time CCI monitoring in high-speed production lines

7. Needle Clogging and Delivery Issues

Needle blockage can prevent complete drug administration and compromise device usability.

Causes

  • High-viscosity formulations crystallizing in the needle lumen during storage

  • Evaporation or moisture ingress through the needle cap

  • Inadequate sealing between needle and cap

Solutions

  • Maintain controlled storage conditions (temperature, humidity)

  • Design airtight needle shields with moisture barrier properties

  • Retain a micro air gap in the needle to prevent solution migration

  • Conduct accelerated clogging simulations for stability verification

8. Labeling, Traceability, and User Handling

Poor labeling or confusing device design can lead to administration errors or misidentification.

Causes

  • Low contrast or unclear label printing

  • Inadequate adhesive strength or label slippage under cold storage

  • Lack of ergonomic consideration for patient self-injection

Solutions

  • Use high-contrast, low-migration inks compatible with sterilization methods

  • Validate adhesive performance under all storage conditions

  • Conduct human factors and usability testing to enhance patient safety

  • Integrate 2D barcodes and serialization for traceability and anti-counterfeiting

9. Ensuring Material Compatibility and Stability

Drug–container interactions must be systematically evaluated to prevent degradation, adsorption, or leaching.

Solutions

  • Conduct extractables and leachables (E&L) studies under ICH Q3D and USP <1664> guidelines

  • Perform adsorption/desorption studies to evaluate drug loss

  • Test chemical stability across temperature and time profiles

  • Select low-reactivity materials such as fluoropolymer-coated elastomers and high-purity COP syringes

Quality-by-Design (QbD) Approach for Prefilled Syringe Development

A robust QbD framework is essential for identifying critical quality attributes (CQAs) and process parameters (CPPs):

  • Define CQAs: plunger force, particle level, extractables, fill accuracy, CCI

  • Control CPPs: siliconization, glass forming, filling speed, sealing pressure

  • Implement process analytical technology (PAT) for real-time quality monitoring

  • Validate every stage under GMP and ISO 11040 standards

Summary

Prefilled syringe manufacturing is a precision-driven process that demands holistic control of materials, design, and manufacturing parameters. The main challenges—ranging from silicone oil migration and glass delamination to protein aggregation and sealing failure—can be effectively mitigated through proper material selection, optimized process control, and advanced inspection systems.

By integrating high-quality engineering practices, automated inspection technologies, and continuous process validation, manufacturers can significantly enhance the safety, performance, and reliability of prefilled syringe products.

Contact for Technical Consultation

Zhejiang Leadtop Pharmaceutical Machinery Co., Ltd (LTPM CHINA) provides complete turnkey solutions for syringe filling, assembly, and inspection systems.
We offer:

  • Customized PFS filling and sealing machines

  • Vision inspection systems for defect detection and CCI verification

  • Material compatibility assessment and validation support

  • Five-year warranty and technical training for operators